Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-12261.71%
operating margin TTM
1086.33%
revenue TTM
1.86 Million
revenue per share TTM
0.03$
valuation ratios | |
|---|---|
| pe ratio | -3.05 |
| peg ratio | 0.19 |
| price to book ratio | 1.52 |
| price to sales ratio | 373.59 |
| enterprise value multiple | -5.53 |
| price fair value | 1.52 |
profitability ratios | |
|---|---|
| gross profit margin | -166.35% |
| operating profit margin | 1086.33% |
| pretax profit margin | -12356.0% |
| net profit margin | -12261.71% |
| return on assets | -38.63% |
| return on equity | -41.27% |
| return on capital employed | 3.83% |
liquidity ratios | |
|---|---|
| current ratio | 5.17 |
| quick ratio | 5.17 |
| cash ratio | 1.07 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 2.60 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 2.60 |
| receivables turnover | 140.17 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 36.84 |
| cash flow to debt ratio | -42.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.03 |
| cash per share | 1.96 |
| operating cash flow per share | -0.93 |
| free cash flow operating cash flow ratio | 1.12 |
| cash flow coverage ratios | -42.01 |
| short term coverage ratios | -109.78 |
| capital expenditure coverage ratio | -8.62 |
Frequently Asked Questions
When was the last time Perspective Therapeutics, Inc. (AMEX:CATX) reported earnings?
Perspective Therapeutics, Inc. (CATX) published its most recent earnings results on 10-11-2025.
What is Perspective Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Perspective Therapeutics, Inc. (AMEX:CATX)'s trailing twelve months ROE is -41.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Perspective Therapeutics, Inc. (CATX) currently has a ROA of -38.63%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CATX's net profit margin stand at?
CATX reported a profit margin of -12261.71% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CATX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.17 in the most recent quarter. The quick ratio stood at 5.17, with a Debt/Eq ratio of 0.01.